We only have this paper's title and publication details.
Read it at the sourceDecr2 knockdown leads to ferroptosis resistance in tumors, suggesting implications for immunotherapy efficacy.
Supplementary Figure S11. Decr2 knockdown tumors are resistant to ferroptosis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: